Unknown

Dataset Information

0

Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II.

ABSTRACT: Hyperprolinemia type II (HPII) is an inborn error of metabolism due to genetic variants in ALDH4A1, leading to a deficiency in Δ-1-pyrroline-5-carboxylate (P5C) dehydrogenase. This leads to an accumulation of toxic levels of P5C, an intermediate in proline catabolism. The accumulating P5C spontaneously reacts with, and inactivates, pyridoxal 5'-phosphate, a crucial cofactor for many enzymatic processes, which is thought to be the pathophysiological mechanism for HPII. Here, we describe the use of a combination of LC-QTOF untargeted metabolomics, NMR spectroscopy and infrared ion spectroscopy (IRIS) to identify and characterize biomarkers for HPII that result of the spontaneous reaction of P5C with malonic acid and acetoacetic acid. We show that these biomarkers can differentiate between HPI, caused by a deficiency of proline oxidase activity, and HPII. The elucidation of their molecular structures yields insights into the disease pathophysiology of HPII.

SUBMITTER: Merx J 

PROVIDER: S-EPMC9492674 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Hyperprolinemia type II (HPII) is an inborn error of metabolism due to genetic variants in ALDH4A1, leading to a deficiency in Δ-1-pyrroline-5-carboxylate (P5C) dehydrogenase. This leads to an accumulation of toxic levels of P5C, an intermediate in proline catabolism. The accumulating P5C spontaneously reacts with, and inactivates, pyridoxal 5'-phosphate, a crucial cofactor for many enzymatic processes, which is thought to be the pathophysiological mechanism for HPII. Here, we describe the use o  ...[more]

Similar Datasets

Unknown Functional properties and structural characterization of rice δ(1)-pyrroline-5-carboxylate reductase.
| S-EPMC4517315 | biostudies-literature
Unknown Δ(1)-pyrroline-5-carboxylate/glutamate biogenesis is required for fungal virulence and sporulation.
| S-EPMC3767830 | biostudies-literature
Unknown Disease variants of human Δ<sup>1</sup>-pyrroline-5-carboxylate reductase 2 (PYCR2).
| S-EPMC8120637 | biostudies-literature
Unknown Evolution of plant δ(1)-pyrroline-5-carboxylate reductases from phylogenetic and structural perspectives.
| S-EPMC4522605 | biostudies-literature
Unknown Enzymology and Regulation of δ<sup>1</sup>-Pyrroline-5-Carboxylate Synthetase 2 From Rice.
| S-EPMC8480329 | biostudies-literature
Unknown The three-dimensional structural basis of type II hyperprolinemia.
| S-EPMC3372638 | biostudies-literature
Unknown Identification of Δ<sup>1</sup>-pyrroline 5-carboxylate synthase (P5CS) genes involved in the synthesis of proline in Lotus japonicus.
| S-EPMC5703238 | biostudies-literature
Unknown Celastrol Combats Methicillin-Resistant Staphylococcus aureus by Targeting Δ<sup>1</sup> -Pyrroline-5-Carboxylate Dehydrogenase.
| S-EPMC10477891 | biostudies-literature
Unknown Functional Impact of a Cancer-Related Variant in Human Δ<sup>1</sup>-Pyrroline-5-Carboxylate Reductase 1.
| S-EPMC9878632 | biostudies-literature
Unknown Functional Characterization of Four Putative δ<sup>1</sup>-Pyrroline-5-Carboxylate Reductases from <i>Bacillus subtilis</i>.
| S-EPMC5539093 | biostudies-literature